StockData
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd (BNR) stock

BNRNasdaqServices-Medical Laboratories
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$13.07+0.57 (+4.56%)

Close on Nov 18, 2026Market cap $142.28MP/E –Yield –

Burning Rock Biotech revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was CN¥539.57M, up 4.6% from the year before. The highest annual figure on record is CN¥563.24M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025CN¥539.57M+4.6%
FY2024Dec 31, 2024CN¥515.82M-4.0%
FY2023Dec 31, 2023CN¥537.44M-4.6%
FY2022Dec 31, 2022CN¥563.24M+10.9%
FY2021Dec 31, 2021CN¥507.86M+18.1%
FY2020Dec 31, 2020CN¥429.90M+12.6%
FY2019Dec 31, 2019CN¥381.68M+82.7%
FY2018Dec 31, 2018CN¥208.87M–

More Burning Rock Biotech figures

See a number that looks wrong?